- Home
- NHTC vs OTLK Comparison
NHTC vs OTLK Comparison
Compare NHTC & OTLK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NHTC
- OTLK
- Stock Information
- Founded
- NHTC 1988
- OTLK 2010
- Country
- NHTC United States
- OTLK United States
- Employees
- NHTC N/A
- OTLK N/A
- Industry
- NHTC Diversified Commercial Services
- OTLK Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NHTC Miscellaneous
- OTLK Health Care
- Exchange
- NHTC Nasdaq
- OTLK Nasdaq
- Market Cap
- NHTC 56.0M
- OTLK 48.3M
- IPO Year
- NHTC 1995
- OTLK 2016
- Fundamental
- Price
- NHTC $5.00
- OTLK $1.53
- Analyst Decision
- NHTC
- OTLK Strong Buy
- Analyst Count
- NHTC 0
- OTLK 5
- Target Price
- NHTC N/A
- OTLK $10.20
- AVG Volume (30 Days)
- NHTC 19.3K
- OTLK 278.4K
- Earning Date
- NHTC 04-30-2025
- OTLK 05-19-2025
- Dividend Yield
- NHTC 16.00%
- OTLK N/A
- EPS Growth
- NHTC N/A
- OTLK N/A
- EPS
- NHTC 0.04
- OTLK N/A
- Revenue
- NHTC $42,749,000.00
- OTLK N/A
- Revenue This Year
- NHTC N/A
- OTLK N/A
- Revenue Next Year
- NHTC N/A
- OTLK $288.46
- P/E Ratio
- NHTC $124.96
- OTLK N/A
- Revenue Growth
- NHTC N/A
- OTLK N/A
- 52 Week Low
- NHTC $4.02
- OTLK $0.87
- 52 Week High
- NHTC $7.40
- OTLK $9.25
- Technical
- Relative Strength Index (RSI)
- NHTC 51.78
- OTLK 55.94
- Support Level
- NHTC $4.88
- OTLK $1.35
- Resistance Level
- NHTC $5.03
- OTLK $1.62
- Average True Range (ATR)
- NHTC 0.10
- OTLK 0.10
- MACD
- NHTC 0.01
- OTLK -0.00
- Stochastic Oscillator
- NHTC 65.22
- OTLK 54.55
About NHTC Natural Health Trends Corp.
Natural Health Trends Corp is an international direct-selling and e-commerce company. It offers a line of products such as Wellness, Herbal, Beauty, Lifestyle, and Home. Wellness products include targeted nutrition for joint health, antioxidant support, digestive health, heart health, and vision health. Herbal products include anti-aging and hydrating cleansers, creams, lotions, serums, and toners. Lifestyle products improve the overall quality of life and to support active, physical and healthy lifestyles. Home products are designed to create a clean and natural living environment for the home. It generates a majority of its revenue from Hong Kong and rest from China, Taiwan, Japan, United States and other regions.
About OTLK Outlook Therapeutics Inc.
Outlook Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications. The Company have received marketing authorization for an ophthalmic formulation of ONS-5010/LYTENAVA (bevacizumab-gamma) for use in treating wet age-related macular degeneration, or wet AMD, in the European Union, and United Kingdom. The product pipeline includes ONS-5010/LYTENAVA which is in total eight NORSES; ONS-5010 Clinical Progress, Unmet Patient Needs, New Ophthalmic Anti-VEGF, and Potential First Line Therapy.